<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465263/" ref="ordinalpos=439&amp;ncbi_uid=4296681&amp;link_uid=PMC3465263" image-link="/pmc/articles/PMC3465263/figure/pone-0046719-g010/" class="imagepopup">Figure 10. Possible points of interaction between Pcmt1 and the upstream insulin-<span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Wortmannin Reduces Insulin <span class="highlight" style="background-color:">Signaling</span> and Death in Seizure-Prone Pcmt1−/− Mice. </a></div><br /><div class="p4l_captionBody">Wortmannin inhibits PI3K class kinases and has been shown to inhibit insulin signaling. The elevated insulin signaling in Pcmt1−/− animals could arise from aberrant Akt activation (hypothesis 1 or 2), and/or aberrant interaction between Akt1 and mTOR (hypothesis 1 or 2) or activation of an alternate growth pathway (hypothesis 3).</div></div>